Today: 8 Fevereiro 2026
Subscribe
Search result

Phantom 4 RTK/feed/category/dji-mavic-3e-pl- Page 174

TSMC Stock Soars on AI Boom: Record Highs, Big Ambitions & Geopolitical Risks (Oct 2025 Update)

TSMC Stock Soars on AI Boom – Record Highs, Key News, Risks & 2025 Outlook

TSMC shares surged to around $294, briefly topping $300, after Q3 2025 revenue rose 30% year-on-year to T$989.9 billion ($32.5 billion), beating forecasts on strong AI chip demand. The stock is up 45% year-to-date, pushing market cap above $1.1 trillion. Taiwan rejected U.S. calls to shift half of TSMC’s production stateside, insisting the majority will remain in Taiwan. Q3 earnings are due October 16.
10 Outubro 2025
··
Strata Skin Sciences (SSKN) Stock Surges on Laser-Therapy Breakthrough – Buy, Hold or Sell?

Strata Skin Sciences (SSKN) Stock Surges on Laser-Therapy Breakthrough – Buy, Hold or Sell?

Strata shares jumped about 63% in pre-market trading on Oct. 14, 2025, after the company announced a clinical case study showing its XTRAC laser nearly cleared lesions of a rare skin lymphoma. The stock, which closed at $1.54 on Oct. 13, spiked into the mid-$2 range in extended hours. Trading volume surged to 45.6 million shares, far above the 6 million average.
14 Outubro 2025
·
ASML Stock Surges on AI Boom but Faces China Headwinds – What Investors Must Know

ASML Stock Surges on AI Boom but Faces China Headwinds – What Investors Must Know

ASML shares traded near €847 on October 15, close to record highs, after a strong Q3 earnings report and robust guidance. The company warned 2026 sales could be flat as China demand drops amid U.S.-China tech tensions and new export controls. ASML invested €1.3 billion in Mistral AI and named Marco Pieters as CTO for 2026. Order backlog hit a record €33 billion, driven by demand from TSMC and other chipmakers.
15 Outubro 2025
··
Datavault AI (DVLT) Stock Skyrockets on Bitcoin Deal & AI Hype – Is the 400% Rally Sustainable?

Datavault AI (DVLT) Stock Skyrockets on Bitcoin Deal & AI Hype – Is the 400% Rally Sustainable?

Datavault AI (NASDAQ: DVLT) surged nearly 30% to $2.19 on Oct. 14, capping a 400% rally since September amid heavy trading and speculation. The company secured a $150 million Bitcoin-funded investment from Scilex and signed a letter of intent to acquire NYIAX Inc. Analyst opinions remain split, with price targets ranging from $3 to $11. DVLT regained Nasdaq compliance as trading volume and volatility spiked.
15 Outubro 2025
····
Achieve Life Sciences Skyrockets on FDA Boost – Is This Nicotine Addiction Breakthrough a Game Changer?

Achieve Life Sciences Skyrockets on FDA Boost – Is This Nicotine Addiction Breakthrough a Game Changer?

Achieve Life Sciences shares jumped over 20% in pre-market trading Friday after receiving an FDA Commissioner’s National Priority Voucher for its lead drug, cytisinicline. The FDA also accepted Achieve’s New Drug Application for cytisinicline as a smoking cessation treatment, with a decision expected by June 2026. ACHV stock reached multi-month highs near $3 following the news. The company’s market cap is about $160 million.
17 Outubro 2025
··
Beyond Meat’s Shocking Collapse: BYND Stock Crashes Below $1 Amid Debt Deal Chaos

Beyond Meat’s Shocking Collapse: BYND Stock Crashes Below $1 Amid Debt Deal Chaos

Beyond Meat shares plunged nearly 60% in one day, closing at $0.65 on Oct. 17 after a debt-for-equity swap triggered a flood of 316 million new shares. Founder and CEO Ethan Brown resigned from the board as analysts warned of a “death spiral.” The company reported Q2 revenue down 20% year-over-year and a net loss of $33 million. Cash reserves have dwindled to $117 million against $1.2 billion in debt.
18 Outubro 2025
·
Psychedelic Biotech Rally: Atai Life Sciences Stock Soars 18% on FDA Breakthrough and $130M Fundraise

Psychedelic Biotech Rally: Atai Life Sciences Stock Soars 18% on FDA Breakthrough and $130M Fundraise

Atai Life Sciences shares surged 18% to close near $6.45 on Oct. 17, 2025, after the FDA granted Breakthrough Therapy status to its experimental depression nasal spray BPL-003. The company raised $130 million in a public offering at $5.48 per share. Analysts issued strong Buy ratings with targets up to $15. ARK Invest disclosed buying about 250,000 shares.
18 Outubro 2025
·
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 19.10.2025

China blocked Ant Group and JD.com from launching stablecoins, reinforcing state control over digital currency. U.S. stock futures rose ahead of a packed earnings week, with Tesla and Netflix among companies reporting. IonQ reported Q3 revenue up 102% to $12.4 million but posted a $52.5 million net loss, while Nvidia posted record Q3 revenue of $35.1 billion.
19 Outubro 2025
···········
Digi Power X (DGXX) Stock Soars on AI Data Center Breakthrough and Crypto Gains

Digi Power X (DGXX) Stock Soars on AI Data Center Breakthrough and Crypto Gains

Digi Power X (NASDAQ: DGXX) traded near $3.85 on Oct. 17, up 10% for the week after its ARMS 200 modular AI data center received ANSI/TIA-942 Tier III certification. The company reported Q2 equity raises of $12.9M, eliminated long-term debt, and posted positive adjusted EBITDA. Its first ARMS 200 pod will be delivered in Alabama by November. Analyst consensus averages “Hold,” with a $3.17 price target.
20 Outubro 2025
····
South Indian Bank Stock Soars to Record High on Q2 Earnings – Will ₹50 Be Next?

South Indian Bank Stock Soars to Record High on Q2 Earnings – Will ₹50 Be Next?

South Indian Bank shares hit a record ₹38.44 on October 21, 2025, after strong Q2 earnings and a surge in trading volumes. Net profit rose 8.2% to ₹351.6 crore, while gross NPA fell to 2.93%. High-net-worth investor Aditya Kumar Halwasiya bought a 0.76% stake during the rally. Brokerages raised targets to ₹42, citing improved fundamentals and steady loan growth.
21 Outubro 2025
··
Newegg Commerce (NEGG) Stock Rockets on AI & “Meme” Hype — 688% YTD Gains, CEO Upgraded to Board

Newegg Commerce (NEGG) Stock Rockets on AI & “Meme” Hype — 688% YTD Gains, CEO Upgraded to Board

Newegg shares jumped 40.8% to close at $66.72 on Oct 24, following a 7% gain the previous day and heavy trading volume. The stock is up roughly 500–600% over the past year, despite sharp volatility. In August, Newegg reported H1 2025 sales of $695.7 million, up 12.6% year-over-year, and turned profitable on an adjusted EBITDA basis. CEO Anthony Chow cited new GPU/CPU launches as key growth drivers.
25 Outubro 2025
·
Hidden ‘Planet-Killer’ Asteroid Found in Sun’s Glare Exposes Dangerous Blind Spot

Hidden ‘Planet-Killer’ Asteroid Found in Sun’s Glare Exposes Dangerous Blind Spot

Astronomers have discovered asteroid 2025 SC79, a 700-meter-wide object orbiting the sun every 128 days—second-fastest known—inside Venus’s orbit. The asteroid, hidden by the sun’s glare until twilight observations, poses no immediate threat to Earth, according to orbital data. Scientists warn similar objects are hard to detect. NASA plans to launch the NEO Surveyor telescope by 2027 to improve detection.
26 Outubro 2025
22nd Century Group (XXII) Soars After $9.5M Windfall, Expands Low-Nicotine Cigarette Rollout

22nd Century Group (XXII) Soars After $9.5M Windfall, Expands Low-Nicotine Cigarette Rollout

22nd Century Group shares surged over 39% in after-hours trading to about $2.10 after securing a $9.5 million insurance settlement. The company, now debt-free, recently expanded its FDA-authorized VLN low-nicotine cigarettes into 140 Circle K stores in Illinois and has sales authorized in 45 states. Despite these moves, 22nd Century remains unprofitable and will report Q3 results on November 4.
29 Outubro 2025
Bristol Myers Squibb (NYSE:BMY) Surges on Q3 Earnings Beat and Raised Outlook – What’s Next for BMY Stock?

Bristol Myers Squibb (NYSE:BMY) Surges on Q3 Earnings Beat and Raised Outlook – What’s Next for BMY Stock?

Bristol Myers Squibb reported Q3 adjusted EPS of $1.63 on $12.2 billion revenue, beating estimates, and raised its 2025 outlook. Shares rebounded 3–4% after hitting a 52-week low, with dividend yield now near 5.5%. New drugs like Opdivo and Eliquis outperformed, offsetting a sharp Revlimid decline. The company acquired Orbital Therapeutics and launched schizophrenia drug Cobenfy, posting $62 million in early sales.
30 Outubro 2025
··
Astera Labs Stock Skyrockets on AI Buzz and Photonics Deal – Can ALAB Keep Climbing?

Astera Labs Stock Skyrockets on AI Buzz and Photonics Deal – Can ALAB Keep Climbing?

Astera Labs shares surged over 12% to $191 intraday on Oct. 31, 2025, though still below their September high of $262.90. The stock rebounded after a volatile month that included a 19% drop on Oct. 15 and the Oct. 22 acquisition of aiXscale Photonics. Q2 revenue jumped 150% year-over-year to $191.9 million, beating estimates. Institutional investors hold about 60% of shares, while insiders sold over $190 million in August.
31 Outubro 2025
··
Virgin Galactic’s Wild 2025 Ride: Space Tourism Liftoff, Stock Surges & Cash Burn – What’s Next for SPCE?

Virgin Galactic’s Wild 2025 Ride: Space Tourism Liftoff, Stock Surges & Cash Burn – What’s Next for SPCE?

Virgin Galactic shares surged over 40% in October 2025 before dropping back, closing at $3.94 on Oct. 31, down about 40% year-to-date and 99% below their 2021 peak. The company paused commercial flights after June 2024 and is burning $100–125 million per quarter, with about 18 months of cash left. Wall Street targets hover near $4, with some analysts warning of further downside.
1 Novembro 2025
··
Hims & Hers Bets Big on “GLP-1 Microdosing” Weight-Loss Trend – Stock and Experts React

Hims & Hers Bets Big on “GLP-1 Microdosing” Weight-Loss Trend – Stock and Experts React

Hims & Hers said Oct. 29 it will offer clinician-supervised GLP-1 “microdose” plans using compounded semaglutide for metabolic health, priced at $1,200 for six months. The drugs, not FDA-approved, target patients with conditions like sleep apnea or high blood pressure. Medical experts warn safety data is limited and compounded versions carry risks. HIMS stock rose 2–3% after the announcement.
3 Novembro 2025
···
Bitcoin Miner to AI Cloud Sensation: Why Iris Energy (IREN) Stock Is Soaring in 2025

From Bitcoin Miner to AI Cloud Powerhouse: Iris Energy’s Meteoric Rise (IREN Stock Soars on $9.7B Microsoft Deal)

Iris Energy (IREN) closed at $67.75 on Nov. 3, 2025, after announcing a $9.7 billion, five-year AI cloud contract with Microsoft, sending shares up 11.5%. The company’s market cap now tops $16.5 billion, up from $1 billion at the start of 2025. IREN posted FY2025 revenue of $501 million and net income of $86.9 million, driven by its pivot to AI cloud services and continued Bitcoin mining.
4 Novembro 2025
···
Kimberly-Clark’s $40 Billion Gamble Sends KMB Stock Plunging – What’s Next for This Dividend King?

Kimberly-Clark’s $40 Billion Gamble Sends KMB Stock Plunging – What’s Next for This Dividend King?

Kimberly-Clark shares plunged 14.6% on Nov. 3 to a 52-week low near $102 after announcing a $40 billion cash-and-stock deal to acquire Kenvue at a 46% premium. The drop erased about 15% of KMB’s market value, with the stock now down 21% year-over-year. Investors cited concerns over Kenvue’s litigation risks and debt load. KMB trades at 17.3× earnings, with a 4.9% dividend yield.
4 Novembro 2025
··
1 … 172 173 174 175 176

Stock Market Today

No $2,000 IRS stimulus check is coming in February 2026 — but Trump’s tariff-check talk keeps the rumors alive

Nenhum cheque de estímulo de US$ 2.000 do IRS chegará em fevereiro de 2026 — mas discurso de Trump sobre “cheques das tarifas” mantém os rumores vivos

7 Fevereiro 2026
Nenhum novo cheque de estímulo federal está previsto para fevereiro de 2026; o IRS não anunciou pagamentos e o Congresso não aprovou medidas. Trump afirmou à NBC que avalia cheques de reembolso tarifário de US$ 2.000, mas sem compromisso ou prazo definido. O IRS alerta para golpes envolvendo promessas falsas de pagamentos.
Go toTop